Calling all media inquiries! Pay attention to our recent findings and give us a call to talk to the expert directly. Contact Liz Moore to schedule some time to get insightful, unbiased, fact-based answers to your questions.
Percentage of drugs in Part D plans that require coinsurance increased significantly since 2014. Medicare Advantage plans require coinsurance far less often than Part D plans.
Avalere and Inovalon have entered into a multi-year agreement with Kindred Healthcare, Inc., the nation’s largest provider of post-acute care (PAC) services, to deploy the power of data and analytics to engage payers. The combined solutions will result in a data-driven platform that will support Kindred in improving clinical outcomes and promoting coordinated, efficient care under new value-based payment models.
A new analysis by Avalere finds that, despite efforts by policymakers to encourage broader vaccination rates, Medicare enrollees have limited access to a set of 10 recommended vaccines without having to pay out-of-pocket (e.g., co-payments).
President Obama released his budget for the 2017 fiscal year today. Avalere offers the following observations on the healthcare proposals:
Today, the Department of Health and Human Services (HHS) announced that 9.6 million individuals selected a health insurance plan on HealthCare.gov during the recent open enrollment season. Avalere estimates that 2016 year-end enrollment will slightly exceed the Obama administration's goal of enrolling 10 million people.
A new analysis from Avalere Health finds that hospitals and health systems are increasingly taking risk for the cost of Medicare patients and the quality of the care they receive.
A new analysis by Avalere finds that the Centers for Medicare and Medicaid Services (CMS) underpay Medicare Advantage (MA) plans for the costs of treating individuals with multiple chronic conditions.
Fred Bentley, an experienced leader in payment and delivery system reform, has joined Avalere’s Center for Payment & Delivery Innovation. Fred will supplement our existing deep expertise in provider strategy and provide analytic and strategic support on issues related to care delivery.
Sheila Fifer, PhD, and Randel Richner, BSN, MPH, have joined Avalere as senior advisors.
We are excited to share with you the next phase in Avalere’s journey.
Avalere won second place in the 2nd Annual LINK Innovation Competition for its Vantage Care Positioning System (CPS).
Avalere senior vice president, Gillian Woollett, has been appointed to the U.S. Pharmacopeial Convention’s Nomenclature and Labeling Expert Committee (NLEC).
A new Avalere assessment of the quality measures landscape shows that many important medical conditions are not fully represented in Medicare pay-for-quality programs, which limits Medicare's ability to pay for value.
New research from Avalere finds that despite the innovation of abuse-deterrent properties and labeling for branded opioids, Medicare Part D plan coverage for these products is declining rapidly.
Avalere Health today announced the hiring of Nancy McGee as executive vice president to head its thriving life sciences business unit.
Avalere director, Leigh Ann Bruhn, was recently named to the Academy of Managed Care Pharmacy’s (AMCP) Corporate Member Council.
Avalere director Dr. Lakshman Ramamurthy will be a panelist on the Centers for Medicare and Medicaid Services’ (CMS) Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), which will meet on Tuesday, March 24.
Lisa Latts, MD, and Rick Smith join Avalere's team.
In 2015, Avalere Health and the Center for Medical Technology Policy will work together to develop the Partnership for Enhanced Recovery to promote broader adoption of proven protocols in the surgical space across a number of US hospitals.
Sheahan will lead Avalere Communications, a rapidly growing group within Avalere Health that brings deep substantive and innovative strategic thinking to healthcare communications.